Genmab — November 2020

[GeorgeBest]

Lommepenge for Sanofi, men...

[nohope]

275 % i præmie - mums

[nohope]

Ring og tilbyd dem GEN.

[E_L]

in july: "Kiadis licenses previously undisclosed pre-clinical K-NK-cell programs to Sanofi, with total potential
deal value of €875 million, plus royalties", in that light it is not so much... , i guess investors did not expect that to be payed out...

[E_L]

this could have easily happened to JNJ/ Genmab at dkk500 only a few years ago...

[nohope]

Approx 1900 DKK in spring 2015? That would have been great !

[E_L]

lol, I was more thinking about a 500sales price; that would have been a bit less great

[E_L]

Monoclonal Antibodies to Treat Multiple Myeloma: https://www.mdpi.com/1422-0067/21/21/8192/htm

[E_L]

-- TEPEZZA (teprotumumab-trbw) Third-Quarter 2020 Net Sales of $286.9 Million; Increasing Full-Year 2020 Guidance to Greater Than $800 Million from Greater Than $650 Million; Significantly Increasing Investment in TEPEZZA to Support Continued Strong Growth --

[E_L]

Pursuing TEPEZZA Expansion Outside the United States -- https://ir.horizontherapeutics.com/news-releases/news-release-details/horizon-therapeutics-plc-reports-record-third-quarter-2020

[E_L]

the Dara- Duobodies combo-trial adds pomalidomide https://clinicaltrials.gov/ct2/history/NCT04108195?A=12&B=13&C=merged#StudyPageTop

[Solsen]

Tapezza er vildt. Helt uretfærdigt falder Horizon ved åbning.

[Solsen]

Når nærmest at blive blockbuster på et år.

[Solsen]

Alene $3bn i US. Hvad kan det ikke blive når ROW kommer med. Den aktie skal højt op. Vi Genmab aktionærer får også glæde af store tal.

[iboge]

Hvor meget får Genmab ?

[Solsen]

Blev vi ikke enige om 7%.

[iboge]

Ok, Tak Solsen.

[Solsen]

Måske 6% Vil tro at Genmabs regnskab snart afslører procenten.

[Solsen]

Ikke umuligt at Tapezza rammer $5bn og $350 mln eller 33 kr pr aktie årligt til Genmab

[Solsen]

Det er langt over tidligere forventninger.